Patent · US Active

Compounds inclunding substituted pyridines for inflammation and immune-related uses

US8314130B2 · kind B2 · utility

0Cited by

14References

8Claims

0Family size

Assignee

Synta Pharmaceuticals Corp. · US

Inventors

Shoujun Chen · Bedford, US
Junyi Zhang · Lowell, US
Jun Jiang · Shanghai, CN
Gary Bohnert · Cambridge, US
Nha Huu Vo · Southborough, US
Qinglin Che · Foxborough, US
Zhiqiang Xia · Acton, US
Lijun Sun · Harvard, US

Key dates

Filing date	Oct 1, 2009
Grant date	Nov 20, 2012
Priority date	—
Expiry date	Oct 1, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to certain compounds including substituted pyridines, or pharmaceutically acceptable salts, solvates, clathrates, or prodrugs thereof, that are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.